Octavio Espinoza
Chief Financial Officer · 2 filings · Latest: May 27, 2026
LIGAND PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
LGND | Octavio Espinoza | Chief Financial Officer | May 27, 2026 | Option Exercise | $57.58 | 1,736 | $100.0K | 27,679 | |
LGND | Octavio Espinoza | Chief Financial Officer | Mar 2, 2026 | Grant/Award | $0.00 | 4,933 | — | 37,945 | |